New Paper from WuXi AppTec on Shortening Timelines for Bioprocessing of Protein-Based Therapeutics

Sartorius Stedim Biotech (SSB) today announced a new paper entitled, ‘Shortening Timelines for Upstream Bioprocessing of Protein-based Therapeutics’ has been published in the journal, BioPharma Asia.

The paper details how scientists at leading Asian pharmaceutical company, WuXi AppTec are using the ambr^® 15 automated micro bioreactor system to mimic bench-top and production scale bioreactors, producing comparable results with cell growth, cell metabolism and protein production, including similar protein titre to BIOSTAT^® STR single-use bioreactors.In the article, one case study describes how...

More From BioPortfolio on "New Paper from WuXi AppTec on Shortening Timelines for Bioprocessing of Protein-Based Therapeutics"